Jie Mei

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Transcription Factor

Bioinformatics Analysis

Top Venues

Cancer communications (London, England)

Journal of oncology

Cancer cell international

Journal of experimental & clinical cancer research : CR

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Mei, Yun Cai, Rui Xu, Qing Li, Jiahui Chu, Zhiwen Luo, Yaying Sun, Yuxin Shi, Junying Xu, Di Li, Shuai Liang, Ying Jiang, Jiayu Liu, Zhiwen Qian, Jiaofeng Zhou, Mengyun Wan, Yunlong Yang, Yichao Zhu, Yan Zhang, Yongmei Yin
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade. Cancer communications (London, England) 44 (5) (2024)
Jie Mei, Yun Cai, Rui Xu, Qing Li, Jiahui Chu, Zhiwen Luo, Yaying Sun, Yuxin Shi, Junying Xu, Di Li, Shuai Liang, Ying Jiang, Jiayu Liu, Zhiwen Qian, Jiaofeng Zhou, Mengyun Wan, Yunlong Yang, Yichao Zhu, Yan Zhang, Yongmei Yin
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade. Cancer communications (London, England) 44 (5) (2024)
Jie Mei, Jiahui Chu, Kai Yang, Zhiwen Luo, Jiayue Yang, Junying Xu, Qing Li, Yan Zhang, Qinglin Zhang, Mengyun Wan, Ningyi Xue, Junli Ding, Yichao Zhu, Yun Cai, Yongmei Yin
Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade. Journal for immunotherapy of cancer 12 (9) (2024)
Jie Mei, Yun Cai, Rui Xu, Qing Li, Jiahui Chu, Zhiwen Luo, Yaying Sun, Yuxin Shi, Junying Xu, Di Li, Shuai Liang, Ying Jiang, Jiayu Liu, Zhiwen Qian, Jiaofeng Zhou, Mengyun Wan, Yunlong Yang, Yichao Zhu, Yan Zhang, Yongmei Yin
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade. Cancer communications (London, England) (2024)
Jie Mei, Yun Cai, Rui Xu, Qing Li, Jiahui Chu, Zhiwen Luo, Yaying Sun, Yuxin Shi, Junying Xu, Di Li, Shuai Liang, Ying Jiang, Jiayu Liu, Zhiwen Qian, Jiaofeng Zhou, Mengyun Wan, Yunlong Yang, Yichao Zhu, Yan Zhang, Yongmei Yin
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade. Cancer communications (London, England) 44 (5) (2024)
Junying Xu, Xuejing Yang, Jiadong Pan, Honghong Fan, Jie Mei, Dong Hua
Biochanin A Suppresses Tumor Progression and PD-L1 Expression via Inhibiting ZEB1 Expression in Colorectal Cancer. Journal of oncology 2022 (2022)
Jinlu Zhao, Jie Mei, Fengxu Wang, Xinyuan Zhao, Yi Ren, Xingyu Zhao, Wang Li, Erli Gao
Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer. Journal of oncology 2022 (2022)
Jie Mei, Tiejun Wang, Shaojie Zhao, Yan Zhang
Osthole Inhibits Breast Cancer Progression through Upregulating Tumor Suppressor GNG7. Journal of oncology 2021 (2021)
Jiayue Yang, Cheng Yang, Hong Shen, Wenjun Wu, Zhen Tian, Qinghua Xu, Cuiping Cao, Shugao Ye, Le Ban, Xin Tong, Jie Mei
Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients. Cancer cell international 21 (1) (2021)
Jie Mei, Leiyu Hao, Huiyu Wang, Rui Xu, Yan Liu, Yichao Zhu, Chaoying Liu
Systematic characterization of non-coding RNAs in triple-negative breast cancer. Cell proliferation 53 (5) (2020)
Rui Xu, Jiadong Pan, Jie Mei, Qing-Lin Zhang
Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer. BioMed research international 2020 (2020)
Xiafeng Peng, Han Gao, Rui Xu, Huiyu Wang, Jie Mei, Chaoying Liu
The interplay between HIF-1α and noncoding RNAs in cancer. Journal of experimental & clinical cancer research : CR 39 (1) (2020)
Jingxuan Chen, Yun Cai, Rui Xu, Jiadong Pan, Jie Zhou, Jie Mei
Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico. Cancer cell international 20 (2020)